Date | Wednesday, April 16, 2025
Time | 7:30 PM ET (Please adjust to your time zone accordingly)
Exploring DAXXIFY®: A New Botulinum Toxin Option in the Treatment of Spasmodic Dysphonia
Join us on Wednesday, April 16 for an informative webinar on DAXXIFY® (also known as DAXI), a new botulinum toxin type A being studied for the treatment of spasmodic dysphonia. This session will highlight findings from a clinical trial conducted at the UCSF Voice & Swallowing Center, led by Drs. Clark Rosen and VyVy Young, and will feature expert insights from Dr. VyVy Young and Dr. Lee Akst.
The trial included 22 participants and investigated the safety and efficacy of DAXXIFY® for individuals with adductor spasmodic dysphonia. Preliminary results suggest that DAXXIFY® may offer an extended duration of symptom relief—up to 50% longer between injections compared to traditional BoNT-A treatments. No significant side effects were observed, and voice outcomes were similar to those achieved with current standard therapies.
Whether you’re exploring new treatment options or simply interested in the latest research, this is a valuable opportunity to hear directly from physicians at the forefront of this evolving area of care, so register today! Please note that the webinar will be recorded and available to view after the session.
ABOUT OUR SPEAKERS
VvVy Young, MD
Dr. VyVy Young is an Associate Professor of Clinical Otolaryngology in the Division of Laryngology at the University of California, San Francisco. She earned her medical degree from the University of Louisville, where she graduated summa cum laude and was inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Young completed her residency in Otolaryngology–Head and Neck Surgery under Dr. Jeffrey Bumpous at the University of Louisville. During her training, she received the Francis Lejeune, Sr. Resident Research Award from the Southern Section of the Triological Society. Her clinical and academic work focuses on voice disorders, and she is actively involved in education and leadership within the field of laryngology.
Lee Akst, MD
Dr. Lee Akst is the Director of the Johns Hopkins Voice Center and an Associate Professor of Otolaryngology–Head and Neck Surgery. He is a nationally recognized expert in the diagnosis and treatment of voice and swallowing disorders, with special expertise in office-based laryngeal procedures and phonosurgery. Dr. Akst’s practice emphasizes voice preservation and restoration, using advanced technologies such as pulsed angiolytic lasers and vocal fold injection techniques. He serves in leadership roles within Johns Hopkins Otolaryngology-Head and Neck Surgery, the American Broncho-Esophagological Association, and the American Academy of Otolaryngology–Head and Neck Surgery. His research interests include robotic laryngeal surgery and innovative approaches to managing laryngeal disease.
Clark Rosen, MD
Dr. Rosen is the Director of the UCSF Voice and Swallowing Center, Chief of the Division of Laryngology, and Professor of Otolaryngology–Head and Neck Surgery. He earned his medical degree from Rush University, completed residency at Oregon Health Sciences University, and a fellowship in Laryngology and Upper Airway Physiology at the University of Tennessee. A nationally recognized leader in voice and airway care, he founded the University of Pittsburgh Voice Center and its fellowship in laryngology. Dr. Rosen has authored over 200 publications and several textbooks, and currently serves as President of the American Laryngological Association. Dr. Rosen has been a Co-Investigator on numerous NIH grants as well as grants from the Triological Society, the VA, and private industry.